BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6818318)

  • 1. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.
    Harriman GR; Podack ER; Braude AI; Corbeil LC; Esser AF; Curd JG
    J Exp Med; 1982 Oct; 156(4):1235-49. PubMed ID: 6818318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of C9 in complement-mediated killing of Neisseria.
    Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
    J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
    Schiller NL; Joiner KA
    Infect Immun; 1986 Dec; 54(3):689-94. PubMed ID: 3096887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement binding on serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae: effect of presensitization with a non-bactericidal monoclonal antibody.
    Joiner KA; Puentes SM; Warren KA; Scales RA; Judd RC
    Microb Pathog; 1989 May; 6(5):343-50. PubMed ID: 2505012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunoabsorbent assay for the quantitation of the terminal complement complex from cell membranes or in activated human sera.
    Gawryl MS; Simon MT; Eatman JL; Lint TF
    J Immunol Methods; 1986 Dec; 95(2):217-25. PubMed ID: 3794343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.
    Joiner KA; Warren KA; Brown EJ; Swanson J; Frank MM
    J Immunol; 1983 Sep; 131(3):1443-51. PubMed ID: 6411816
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation.
    Griffiss JM; Jarvis GA; O'Brien JP; Eads MM; Schneider H
    J Immunol; 1991 Jul; 147(1):298-305. PubMed ID: 1711080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi.
    Breitner-Ruddock S; Würzner R; Schulze J; Brade V
    Med Microbiol Immunol; 1997 Mar; 185(4):253-60. PubMed ID: 9138298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of C9-deficient human serum.
    Pramoonjago P; Kinoshita T; Hong KS; Takata-Kozono Y; Kozono H; Inagi R; Inoue K
    J Immunol; 1992 Feb; 148(3):837-43. PubMed ID: 1730876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae.
    Schneider H; Griffiss JM; Mandrell RE; Jarvis GA
    Infect Immun; 1985 Dec; 50(3):672-7. PubMed ID: 3934078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.